» Articles » PMID: 28260858

Systemic Abnormalities Associated with Retinal Vein Occlusion in Young Patients

Overview
Journal Clin Ophthalmol
Publisher Dove Medical Press
Specialty Ophthalmology
Date 2017 Mar 7
PMID 28260858
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To study the systemic abnormalities associated with retinal vein occlusion in patients aged ≤50 years with a particular emphasis on atherosclerotic diseases and thrombophilic disorders.

Methods: Medical charts of patients, aged ≤50 years whose diagnoses were retinal vein occlusions during the period 1995-2015 were retrospectively reviewed. The primary outcome was the number of systemic abnormalities associated with these patients. Secondary outcomes included types of retinal vein occlusion and sites of occlusion.

Results: Atherosclerotic diseases were the most common systemic abnormalities associated with retinal vein occlusion and accounted for 55.1% of the patients in the study. Hypertension in 27.55%, diabetes mellitus in 16.33%, and 5.1% with dyslipidemia were noted. The number of thrombophilic disorders seemed to be less than expected and were noted in only 5.1%. Other systemic abnormalities included viral hepatitis infection, systemic lupus erythematosus, and acquired immunodeficiency syndrome. Oral contraceptives were used by some patients.

Conclusion: Atherosclerotic diseases remained the most commonly associated systemic diseases in the majority of these patients. Approach to these patients should include a screening for hypertension, diabetes mellitus, and lipid abnormalities. Thrombophilia should also be considered where no obvious atherosclerotic diseases are found or if the patient is <40 years old, a history of thrombosis or a family history of thrombosis is possible.

Citing Articles

Cumulative effect of metabolic syndrome on the risk of retinal vein occlusion in young patients: A nationwide population-based study.

Kim Y, Kim C, Kim J, Han K, Kim J PLoS One. 2024; 19(5):e0303871.

PMID: 38768233 PMC: 11104591. DOI: 10.1371/journal.pone.0303871.


Case series of retinal vein occlusions showing early recovery using oral l-methylfolate.

Baker S, Baker D, Baker R, Brown C Ther Adv Ophthalmol. 2024; 16:25158414241240687.

PMID: 38628356 PMC: 11020740. DOI: 10.1177/25158414241240687.


Acute, Treatment-Naïve Branch Retinal Vein Occlusion in Younger Individuals: Risk Factors and Clinical Outcomes.

Kundu A, Thomas A, Mirzania D, Kim J, Stinnett S, Fekrat S J Vitreoretin Dis. 2024; 8(1):51-57.

PMID: 38223779 PMC: 10786076. DOI: 10.1177/24741264231205378.


Central retinal vein occlusion in young population: risk factors and outcomes.

Berguig J, Abdelmassih Y, Azar G, Lafolie J, Alonso A, Bonnin S Front Med (Lausanne). 2023; 10:1180234.

PMID: 37601780 PMC: 10436307. DOI: 10.3389/fmed.2023.1180234.


The Risk of Retinal Vein Occlusion in Young Patients with Mental Disorders: A Nationwide Cohort Study.

Lee J, Wang S, Jeon S, Kim M, Han K, Roh Y J Clin Med. 2023; 12(14).

PMID: 37510989 PMC: 10381617. DOI: 10.3390/jcm12144874.


References
1.
Chiang C, Begley S, Henderson S . Central retinal vein occlusion due to hyperviscosity syndrome. J Emerg Med. 2000; 18(1):23-6. DOI: 10.1016/s0736-4679(99)00157-2. View

2.
Ahluwalia J, Rao S, Varma S, Gupta A, Bose S, Masih J . Thrombophilic risk factors are uncommon in young patients with retinal vein occlusion. Retina. 2014; 35(4):715-9. DOI: 10.1097/IAE.0000000000000366. View

3.
Galli L, Gerdes V, Guasti L, Squizzato A . Thrombosis Associated with Viral Hepatitis. J Clin Transl Hepatol. 2015; 2(4):234-9. PMC: 4521234. DOI: 10.14218/JCTH.2014.00031. View

4.
Rath E, Frank R, Shin D, Kim C . Risk factors for retinal vein occlusions. A case-control study. Ophthalmology. 1992; 99(4):509-14. DOI: 10.1016/s0161-6420(92)31940-2. View

5.
Kotwal R, Butler Jr F, Murray C, Hill G, Rayfield J, Miles E . Central retinal vein occlusion in an Army ranger with glucose-6-phosphate dehydrogenase deficiency. Mil Med. 2010; 174(5):544-7. DOI: 10.7205/milmed-d-00-7608. View